Rating History for CytomX Therapeutics (CTMX) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for CTMX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/16/2026 Anupam Rama Upgrade Overweight
(Neutral)		 12.00
(7.00)		 4.68
(2.95)		 -36.97% Details